| Symbol | HYFT |
|---|---|
| Name | IMMUNOPRECISE ANTIBODIES LTD. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 823 CONGRESS AVE,SUITE 300, AUSTIN, Texas, 78701, United States |
| Telephone | +1 (800) 620-4187 |
| Fax | — |
| — | |
| Website | https://www.ipatherapeutics.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001715925 |
| Description | ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Additional info from NASDAQ: |
New Form EFFECT - MindWalk Holdings Corp. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 9999999995-26-002499 <b>Size:</b> 1 KB
Read moreA Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
Read moreMindWalk Holdings Corp. présente ses résultats pour lexercice 2026 : revenus en hausse de 46% alors que la société finalise sa transition vers une infrastructure dIA bio-native
Read moreAn AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
Read moreMindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
Read moreMindWalk Holdings Corp. (NASDAQ : HYFT) intègre l’indice Russell 3000E, élargissant ainsi les opportunités d’investissement institutionnel
Read moreMindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
Read moreMindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
Read moreLa PDG de MindWalk (NASDAQ : HYFT), Jennifer Bath, participera à la table ronde organisée par Jones AI Day sur l’avenir de la découverte de médicaments par l’IA, à laquelle partipera Absci (NASDAQ : ABSI), un important fournisseur de services dIA...
Read moreMindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
Read more